Long-Term Efficacy and Safety of Immunomodulatory Therapy for Atherosclerosis.

Lakshmi Narasimha ThotaThiruvelselvan PonnusamyXinjie LuLakshmi A Mundkur

Published in: Cardiovascular drugs and therapy (2020)

Our results suggest that immune tolerance to AHC protein by oral administration is able to provide efficient atheroprotection up to 18 weeks and moderately at later stages. Apart from immune regulatory cells, protective antibodies may also have a role in controlling atherosclerosis.

Keyphrases

induced apoptosis
cardiovascular disease
cell cycle arrest
transcription factor
type diabetes
protein protein
oxidative stress
cell death
binding protein
small molecule